Biofrontera Inc. logo

Biofrontera Inc. (BFRI) Q4 2024 Annual Earnings

BFRI·Reported March 21, 2025·Before market open

Biofrontera Inc. reported Q4 2024 revenue of $12.6M, beat analyst consensus of $10.5M by $2.1M. Diluted EPS came in at $-2.33, missed the $0.02 consensus by $2.35.

Revenue
$12.6Mbeat by $2.1M
Consensus: $10.5M
Diluted EPS
$-2.33missed by $2.35
Consensus: $0.02
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q4 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about Biofrontera Inc.'s Q4 2024 earnings report.

Biofrontera Inc. (BFRI) reported Q4 2024 earnings on March 21, 2025 before market open.

Biofrontera Inc. reported revenue of $12.6M and diluted EPS of $-2.33 for Q4 2024.

Revenue beat the consensus estimate of $10.5M by $2.1M. EPS missed the consensus estimate of $0.02 by $2.35.

You can read the 10-K periodic report (0001493152-25-011052) directly on SEC EDGAR. The filing index links above go to sec.gov.